Aelis Farma SA

DB:69O Stock Report

Market Cap: €72.2m

Aelis Farma Future Growth

Future criteria checks 3/6

Aelis Farma's revenue is forecast to decline at 2.1% per annum while its annual earnings are expected to grow at 8.5% per year. EPS is expected to decline by 25% per annum. Return on equity is forecast to be -33.6% in 3 years.

Key information

8.5%

Earnings growth rate

-25.0%

EPS growth rate

Biotechs earnings growth35.5%
Revenue growth rate-2.1%
Future return on equity-33.6%
Analyst coverage

Low

Last updated04 Sep 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:69O - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20265-9-8-53
12/31/20254329-6313
12/31/202425811-113
12/31/202312-5-13-13N/A
9/30/202311-5-13-13N/A
6/30/202310-6-13-13N/A
3/31/20239-10-13-13N/A
12/31/20228-14-13-13N/A
9/30/20228-14-14-13N/A
6/30/20227-14-14-14N/A
3/31/20229-623N/A
12/31/20211111919N/A
9/30/20211022121N/A
6/30/2021932424N/A
3/31/2021511111N/A
12/31/20201-2-3-2N/A
12/31/20190-3N/AN/AN/A
12/31/20180-3N/AN/AN/A
12/31/20170-1N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 69O is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.8%).

Earnings vs Market: 69O is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 69O is expected to become profitable in the next 3 years.

Revenue vs Market: 69O's revenue is expected to decline over the next 3 years (-2.1% per year).

High Growth Revenue: 69O's revenue is forecast to decline over the next 3 years (-2.1% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 69O is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y